INGR News Alert Ingredion Inc (INGR) 86.09 12/25/2014 03:36:

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Ingredion Inc (INGR) 86.09 $INGR

Dividend Challengers: 24 Increases Expected By February 28
David Fish - at Seeking Alpha - Sat Dec 13, 2:17PM CST

HOG: 65.56 (-0.04), LAZ: 50.95 (-0.37), AIV: 37.80 (-0.33), CNP: 23.76 (+0.31), AIT: 46.03 (+0.09), UPS: 112.41 (-0.04), SLB: 87.06 (-0.26), PRI: 54.40 (+0.05), VLO: 49.79 (+0.43), MAT: 30.22 (-0.16), AJG: 47.45 (-0.03), MMLP: 27.41 (-0.91), HME: 66.47 (-0.43), MWE: 66.40 (-0.44), RES: 13.26 (-0.35), INGR: 86.09 (-0.27), PFE: 31.42 (-0.03), ALL: 70.69 (-0.06), CLB: 122.57 (-1.35), RAS: 7.78 (-0.03), MCO: 98.29 (+0.29), FLIR: 33.34 (-0.05), SMP: 38.75 (-0.13), CPA: 101.89 (+0.50), ARCP: 8.33 (unch), HEI: 61.21 (+0.56), EWBC: 38.89 (+0.09), MKTX: 72.30 (+0.01), SNI: 78.54 (+0.85), BCPC: 66.80 (-1.55), FCF: 9.21 (-0.04), GMT: 57.30 (-0.32), ALE: 55.81 (+0.61), TAL: 43.08 (-0.18), EMCF: 25.50 (+1.00), WDR: 49.37 (-0.17), TLLP: 56.04 (+0.46), EPR: 58.50 (unch), EME: 44.55 (-0.10), PCBK: 14.28 (+0.04), X: 26.51 (+0.11), CMS: 35.69 (+0.81), LGCY: 11.86 (-0.49), CUBE: 22.59 (+0.08), AMGN: 160.67 (+3.15), EFX: 82.15 (+0.21), ATK: 113.52 (+0.59), FINL: 22.79 (+0.17), LEA: 98.23 (-0.23), TESS: 28.99 (-0.10), LB: 85.06 (unch), HPY: 55.09 (+0.34), DNB: 122.87 (-0.21), BIP: 41.48 (+0.48), TOO: 26.47 (-0.62), FIBK: 27.46 (-0.17), CNA: 38.93 (-0.06), MOFG: 28.87 (+0.04)

INGREDION BOARD AUTHORIZES NEW 5 MILLION SHARE REPURCHASE PROGRAM and DECLARES QUARTERLY DIVIDEND of $0.42 per SHARE
Thomson Reuters ONE - Fri Dec 12, 10:41AM CST
WESTCHESTER, Ill., December 12, 2014 - The board of directors of Ingredion Incorporated (NYSE: INGR) today authorized a new stock repurchase program permitting purchases of up to five million of Ingredion's outstanding common shares from January 1, 2015 to December 31, 2019.
INGR: 86.09 (-0.27)

Tracking David Tepper's Appaloosa Management Portfolio - Q3 2014 Update
John Vincent - at Seeking Alpha - Fri Nov 21, 7:44AM CST

F: 15.30 (-0.03), PRU: 91.45 (-0.03), AXLL: 41.52 (+0.11), DAL: 48.05 (+0.92), HDS: 29.72 (+0.01), C: 54.54 (+0.12), LO: 63.60 (+0.16), GOOG: 528.77 (-1.82), SLB: 87.06 (-0.26), HUN: 23.39 (-0.13), WHR: 191.15 (+0.02), SPY: 207.77 (+0.02), KBR: 17.00 (-0.13), SHPG: 209.29 (+0.07), WFT: 11.73 (-0.21), AAL: 51.43 (+1.22), DD: 74.79 (-0.40), TEX: 27.96 (-0.10), OC: 35.23 (-0.16), ABBV: 66.21 (+1.86), GOOGL: 536.93 (-1.84), AAPL: 112.01 (-0.53), RAI: 65.45 (-0.19), CBI: 41.94 (-0.17), RYL: 37.32 (-0.01), EMN: 76.80 (+0.04), INGR: 86.09 (-0.27), BRCM: 43.38 (-0.04), FB: 80.77 (+0.16), TGI: 66.82 (-0.01), HAL: 39.70 (-0.18), DIS: 94.42 (-0.27), NXPI: 76.75 (+0.48), MGM: 20.77 (-0.17), MAS: 25.17 (-0.14), PCLN: 1,149.78 (+2.17), ASML: 109.64 (+0.51), UAL: 64.93 (+2.45), HCA: 74.89 (-0.11), GT: 28.22 (-0.05), BIDU: 230.98 (-2.18), QQQ: 104.30 (+0.09), CE: 60.31 (+0.12), MHK: 154.56 (-0.21), EXPE: 89.01 (+0.09), GM: 33.43 (-0.13), AIG: 56.28 (-0.16), CMCSA: 58.07 (+0.17), CBS: 55.70 (-0.13), BABA: 105.95 (+0.43)

INGREDION EXECUTIVES WILL OUTLINE PATH FORWARD AND LONG-TERM OBJECTIVES AT ANALYST DAY TODAY; FOCUS ON HIGH-VALUE SPECIALTY INGREDIENTS
Thomson Reuters ONE - Tue Nov 18, 7:02AM CST
BRIDGEWATER, N.J., November 18, 2014 - Today senior executives of Ingredion Incorporated (NYSE: INGR), a leading global provider of ingredient solutions to diversified industries, will present a business overview to investment analysts. Future growth drivers, financial performance and long-term objectives driving the Company's success will be reviewed. As previously announced, the Analyst Day presentation will be webcast.
INGR: 86.09 (-0.27)

Equity Selections For Your Retirement Portfolios: 39 Dividend Growth Stocks For Total Return: Part 1
Chuck Carnevale - at Seeking Alpha - Tue Nov 18, 6:30AM CST

USTR: 42.04 (-0.13), EPS: 72.85 (+0.01), EMN: 76.80 (+0.04), INGR: 86.09 (-0.27), TEL: 64.59 (-0.12), HAL: 39.70 (-0.18), M: 64.26 (+0.22), AET: 89.59 (+0.14)

Dividend Challengers (And Near-Challengers): 44 Increase Expected By January 31
David Fish - at Seeking Alpha - Mon Nov 17, 3:57AM CST

WDFC: 84.59 (-0.01), EWBC: 38.89 (+0.09), TTC: 63.54 (+0.11), OCR: 73.20 (+0.33), GE: 25.83 (-0.05), MAIN: 30.13 (+0.19), HI: 34.20 (+0.19), DEI: 28.75 (-0.13), BLX: 31.27 (+0.12), THG: 71.98 (+0.36), RL: 184.35 (+0.70), BCPC: 66.80 (-1.55), AET: 89.59 (+0.14), VTR: 71.73 (-0.89), WDR: 49.37 (-0.17), TLLP: 56.04 (+0.46), PCBK: 14.28 (+0.04), EME: 44.55 (-0.10), EPR: 58.50 (unch), CHS: 16.12 (+0.07), LGCY: 11.86 (-0.49), BMR: 21.76 (-0.15), EMN: 76.80 (+0.04), INGR: 86.09 (-0.27), PRA: 47.52 (+0.05), CUBE: 22.59 (+0.08), DIS: 94.42 (-0.27), COR: 38.83 (+0.43), BMY: 59.15 (-0.01), MORN: 66.02 (+0.08), EXL: 13.37 (+0.03), RAS: 7.78 (-0.03), CLB: 122.57 (-1.35), RCII: 36.41 (+0.40), TESS: 28.99 (-0.10), BGS: 31.25 (-0.16), TOO: 26.47 (-0.62), FIBK: 27.46 (-0.17), MAA: 76.00 (-0.21), HEI: 61.21 (+0.56), JCI: 48.50 (-0.23)

INGREDION TO WEBCAST PRESENTATION TO ANALYSTS ON NOVEMBER 18, 2014
Thomson Reuters ONE - Thu Nov 06, 12:29PM CST
WESTCHESTER, Ill., Nov. 6, 2014 - Ingredion Incorporated (NYSE: INGR), a leading global provider of ingredient solutions to diversified industries, will webcast its Analyst Day presentation on Tuesday, November 18, 2014. Ingredion's senior executives will present a business overview, including a review of future growth drivers, financial performance and long-term targets for the Company.
INGR: 86.09 (-0.27)

5 Takeaways From Ingredion's Quarterly Statement
William Bias - at Seeking Alpha - Thu Nov 06, 8:07AM CST

INGR: 86.09 (-0.27)

Ingredion: A Safe Haven With Improving Prospects
Darspal S Mann - at Seeking Alpha - Wed Nov 05, 9:11AM CST

INGR: 86.09 (-0.27)

INVESTOR ALERT: The Law Offices of Vincent Wong Investigates the Board of Directors of Penford Corporation Regarding the Fairness of the Sale of the Company to Ingredion Incorporated - PENX
PR Newswire - Tue Nov 04, 11:04AM CST
The Law Offices of Vincent Wong are investigating potential claims against the Board of Directors of Penford Corporation (NasdaqGM: PENX) ("Penford" in connection with the sale of the Company to Ingredion Incorporated (NYSE: INGR).
INGR: 86.09 (-0.27), PENX: 18.83 (+0.04)

Ingredion Incorporated's (INGR) CEO Ilene Gordon on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Oct 30, 5:40PM CDT

INGR: 86.09 (-0.27)

Ingredion meets 3Q profit forecasts
Automated Insights - Thu Oct 30, 10:24AM CDT
WESTCHESTER, Ill. (AP) _ Ingredion Inc. (INGR) on Thursday reported third-quarter net income of $118.6 million.
INGR: 86.09 (-0.27)

Ingredion beats by $0.01, misses on revenue
Seeking Alpha - at Seeking Alpha - Thu Oct 30, 8:20AM CDT

INGR: 86.09 (-0.27)

INGREDION INCORPORATED REPORTS SOLID THIRD QUARTER 2014 RESULTS
Thomson Reuters ONE - Thu Oct 30, 5:30AM CDT
- Third quarter 2014 EPS rose 45 percent to $1.60 from $1.10 in the third quarter 2013
INGR: 86.09 (-0.27)

Notable earnings before Thursday’s open
Seeking Alpha - at Seeking Alpha - Wed Oct 29, 4:30PM CDT

FIS: 63.62 (-0.42), HST: 24.23 (-0.07), CRR: 40.16 (-0.81), CAH: 82.07 (+0.15), AMT: 100.75 (+0.10), ACIW: 20.76 (+0.12), GTI: 4.84 (-0.04), IDA: 67.37 (+1.01), CRCM: 8.12 (+0.14), CVRR: 16.90 (-0.21), BGCP: 9.06 (-0.10), GOV: 23.32 (-0.03), DFT: 33.68 (+0.03), APO: 23.33 (-0.09), FIG: 7.89 (unch), AMAG: 43.02 (+0.90), HAR: 105.30 (+0.11), AVP: 9.22 (-0.07), EXLS: 28.69 (+0.21), INGR: 86.09 (-0.27), ALU: 3.67 (+0.03), INCY: 71.57 (+1.99), COP: 70.13 (-0.92), GEL: 43.39 (-0.65), COR: 38.83 (+0.43), GTLS: 34.61 (+0.14), BWA: 55.67 (-0.72), CARB: 14.54 (+0.94), GLOP: 25.07 (-0.23), IDCC: 54.33 (+0.15), HEES: 28.38 (-0.59), BCO: 24.09 (-0.03), DST: 95.96 (-0.16), EPD: 35.45 (+0.25), ABMD: 38.46 (+0.13), CEVA: 18.37 (+0.56), BLL: 69.70 (-0.14), GBX: 51.59 (+0.47), GNC: 46.10 (-0.29), CVI: 39.62 (unch), ACOR: 39.14 (+0.74), I: 16.83 (+0.19), FCN: 39.23 (-0.16), CRNT: 0.98 (+0.02), DHX: 10.28 (+0.08), BG: 92.03 (-0.33), CME: 90.58 (-2.14), FCH: 10.80 (-0.06), ALLE: 55.73 (+0.05), AUDC: 4.51 (+0.01), APD: 148.58 (unch), DBD: 35.55 (-0.05), HGG: 7.65 (-0.12), CBM: 21.62 (+0.37), CNSL: 28.07 (+0.32), ATK: 113.52 (+0.59), ANR: 1.60 (-0.02), CI: 104.23 (-0.08), ABC: 91.60 (+0.18), GG: 17.67 (+0.49)

PENFORD CORPORATION SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout
Business Wire - Tue Oct 28, 10:55AM CDT
Rigrodsky & Long, P.A.:
INGR: 86.09 (-0.27), PENX: 18.83 (+0.04)

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of Penford Corporation of Class Action Against the Board of Directors of the Company Regarding the Fairness of the Sale of the Company to Ingredion Incorporated -- PENX
GlobeNewswire - Tue Oct 28, 10:29AM CDT
Levi & Korsinsky notifies investors of Penford Corporation ("Penford" or "the Company" (Nasdaq ENX) of claims of breaches of fiduciary duty and other violations of state law against the board of directors of the Company in connection with the sale of the Company to Ingredion Incorporated (NYSE:INGR). A complaint was filed in Colorado federal court.
INGR: 86.09 (-0.27), PENX: 18.83 (+0.04)

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Launches Investigation of the Board of Directors of Penford Corporation Regarding the Fairness of the Sale of the Company to Ingredion Incorporated -- PENX
Business Wire - Mon Oct 27, 10:01AM CDT
Levi & Korsinsky is investigating the Board of Directors of Penford Corporation ("Penford" or "the Company" (NasdaqGM: PENX) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Ingredion Incorporated (NYSE: INGR).
INGR: 86.09 (-0.27), PENX: 18.83 (+0.04)

INVESTOR ALERT: Levi & Korsinsky, LLP Launches Investigation of the Board of Directors of Penford Corporation Concerning the Fairness of the Sale of the Company to Ingredion Incorporated -- PENX
PR Newswire - Mon Oct 20, 10:05AM CDT
Levi & Korsinsky is investigating the Board of Directors of Penford Corporation ("Penford" or "the Company" (NasdaqGM: PENX) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Ingredion Incorporated (NYSE: INGR).
INGR: 86.09 (-0.27), PENX: 18.83 (+0.04)

Assessing Risk In Equities In The Consumer Staple Sector
Factoids - at Seeking Alpha - Mon Oct 20, 3:04AM CDT

KO: 42.94 (-0.03), MKC: 76.63 (-0.15), CLX: 105.46 (-0.62), CAG: 36.86 (-0.07), HSY: 106.28 (-0.36), INGR: 86.09 (-0.27), KMB: 117.77 (-0.21), HRL: 53.08 (-0.17), SJM: 103.45 (-0.20), PEP: 97.09 (-0.27), K: 67.02 (-0.22), ADM: 53.11 (-0.06), CPB: 44.57 (-0.05), LANC: 93.64 (-1.03), PG: 93.14 (-0.15), FLO: 19.43 (+0.05), GIS: 54.31 (-0.10), CL: 70.47 (-0.53)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 65

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading
Tigerlily Brings HIV Information to Women’s Health

Updated Category News Views 99

A stubborn information gap is exactly where Tigerlily Foundation is planting its flag. The nonprofit’s new national HIV education and awareness campaign, THE POWER OF U, expands work that began in breast cancer advocacy into another area where women need clear facts, trusted voices, and room to speak without being shamed for needing answers. This is not a story that...

Continue Reading
Persistent Dry Eye Symptoms Call for a Closer Look

Updated Category News Views 10

Eyes can turn into a stubborn little nuisance long before people realize something more complicated is going on. A bottle of artificial tears is easy to grab, cheap enough, and often perfectly sensible for a rough day of screens, wind, reading, or air conditioning. But Dr. Harlan Snyder’s point is the one worth sitting with: when dryness keeps barging back despite...

Continue Reading
Allooloo's 100M Calls Test Capital Markets AI Data

Updated Category News Views 160

Forty-one point nine thousand issuers is a lot of financial clutter to keep straight, and Allooloo says its machines are getting called on to do precisely that at industrial scale. The Vancouver-based company reported on November 20 that its capital-markets data products now receive 100 million AI-agent calls a month—roughly 3.4 million daily, or 39 per second. That is...

Continue Reading
Fraud0-FouAnalytics Takes Aim at Legacy Ad Verification

Updated Category News Views 115

Digital ad measurement has spent years grading its own homework, and that little arrangement may finally be getting some daylight. fraud0 and FouAnalytics say their expanded partnership will give advertisers impression-level visibility into where ads actually rendered, whether apparent humans engaged with them, and where wasted Google Ads spend might be recoverable. The...

Continue Reading
Oatly’s $4.13 Tender Offer Is a Legal Detour, Not a Sale

Updated Category News Views 122

A $4.13 cash offer trading against a $7.17 close is the sort of thing that makes investors squint hard, and Verlinvest is practically waving a flag telling them why. This is not a conventional attempt to buy Oatly Group AB. It is a technical tender offer built to satisfy Swedish takeover rules while Verlinvest buys out its joint-venture partner’s interest in Oatly’s...

Continue Reading
Classic Chevrolet Gives $1.145M to 13 Local Groups

Updated Category News Views 104

A Thanksgiving Check With Some Real Weight More than a million dollars changing hands before lunch is not the usual holiday fluff, and Classic Chevrolet's planned $1,145,040 donation deserves more than a quick nod. On Tuesday, November 24, at 11 a.m. CST, the Grapevine dealership says it will distribute that sum among 13 nonprofit organizations and charitable programs...

Continue Reading
Kyverna Probe Reopens IPO Disclosure Questions for Investors

Updated Category News Views 93

Clinical-trial caveats have a nasty habit of becoming shareholder headaches years later. Kyverna Therapeutics is back in that uncomfortable zone after Kahn Swick & Foti said it has opened an investigation into whether the company’s officers and directors breached fiduciary duties or otherwise violated state or federal law. For holders of KYTX, this is not a verdict and...

Continue Reading
California Rideshare Data Exposes an Insurance Gap

Updated Category News Views 52

Three California counties carried an outsized share of rideshare traffic, and the insurance fine print is where this story gets uncomfortable. A review by Mendez & Sanchez says Los Angeles, San Francisco, and San Diego counties accounted for nearly two-thirds of statewide rideshare trips between September 2019 and August 2020. That is an old snapshot, sure, but it points...

Continue Reading
Six LIFE Photographers Bring History Into Florida Focus

Updated Category News Views 96

Seventy photographs can make a pretty loud argument when the historical record has been this lopsided. The Ashley Gibson Barnett Museum of Art at Florida Southern College has brought LIFE: Six Women Photographers to Lakeland, and it deserves more than the usual polite nod given to a traveling museum show. Open since November 14, 2026, and running through March 7, 2027,...

Continue Reading

Top 5 Most Recently Viewed Articles

Antonio Filosa Takes the Helm as CEO of Stellantis N.V.

Updated Category News Views 335

Antonio Filosa Appointed as Stellantis N.V. Chief Executive Officer Stellantis N.V., a prominent player in the global automotive arena, has officially announced the appointment of Antonio Filosa as its new Chief Executive Officer. Filosa, who has amassed over 25 years of experience within the automotive sector, currently holds the position of Chief Operating Officer for...

Continue Reading
Understanding the Edwards Lifesciences Legal Landscape

Updated Category News Views 278

Understanding Recent Legal Issues for Investors In the world of investment, understanding legal implications can often feel overwhelming, especially when a company faces a class action lawsuit. Edwards Lifesciences Corporation, a name recognized for its innovative heart valve technologies, currently finds itself embroiled in legal battles that could shape its future and...

Continue Reading
Arrive Home and FormFree Join Forces to Enhance Homeownership Access

Updated Category News Views 155

Arrive Home Partners with FormFree for Innovative Solutions The innovative collaboration between Arrive Home and FormFree aims to transform the landscape of homeownership for many borrowers facing challenges due to limited credit histories. This partnership is particularly significant as it opens doors for those who have previously been overlooked by traditional credit...

Continue Reading
Verizon's $20 Billion Acquisition: A Strategic Expansion Ahead

Updated Category News Views 76

Verizon Announces Major Acquisition of Frontier Communications Verizon has recently made headlines by announcing a significant acquisition deal with Frontier Communications. This all-cash transaction, valued at $20 billion, underscores Verizon's dedication to substantially expanding its fiber network. Details of the Acquisition According to the proposed terms, Verizon...

Continue Reading
MoxiWorks Enhances Innovation Timeline with New Leadership and Funding

Updated Category News Views 174

MoxiWorks Enhances Innovation Timeline with New Leadership and Funding Funding from private equity and brokerage partners, along with new leadership, is set to transform MoxiWorks, a leading provider of sales and marketing software in the real estate sector. With substantial capital secured from its ownership group, which includes Vector Capital, Howard Hanna Real Estate...

Continue Reading